Literature DB >> 12471566

Molecular diversity and routes of colonization of Candida albicans in a surgical intensive care unit, as studied using microsatellite markers.

François Stéphan1, Mamadou Sialou Bah, Christophe Desterke, Saïda Rézaiguia-Delclaux, Françoise Foulet, Philippe Duvaldestin, Stéphane Bretagne.   

Abstract

To evaluate the colonization of Candida species and the importance of cross-contamination with Candida albicans, we prospectively screened clinical specimens obtained from surgical patients in the intensive care unit (ICU) who had a high risk of yeast colonization. Genotyping of C. albicans was performed using microsatellite markers. Thirty-six of 94 patients acquired nosocomial yeast colonization and/or infection. A total of 1126 specimens were cultured, 167 (15%) of which yielded yeasts. All 122 isolates of C. albicans recovered from the 30 C. albicans-positive patients were genotyped. Twenty-four different genotypes were identified. No genotype was systematically associated with a specific room or time. Isolates recovered from different body sites of patients at different times had identical genotypes. Acquisition of C. albicans in the surgical ICU seems to be mainly endogenous. Microsatellite markers should also be developed for typing non-albicans Candida species to learn whether their epidemiology differs from that of C. albicans.

Entities:  

Mesh:

Year:  2002        PMID: 12471566     DOI: 10.1086/344648

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  18 in total

Review 1.  Prophylaxis and treatment of invasive candidiasis in the intensive care setting.

Authors:  L Ostrosky-Zeichner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10       Impact factor: 3.267

2.  Multicenter collaborative study for standardization of Candida albicans genotyping using a polymorphic microsatellite marker.

Authors:  Dea Garcia-Hermoso; Donna M MacCallum; Timothy J Lott; Paula Sampaio; Maria-José Buitrago Serna; Fréderic Grenouillet; Corné H W Klaassen; Stéphane Bretagne
Journal:  J Clin Microbiol       Date:  2010-04-28       Impact factor: 5.948

3.  [Not Available].

Authors:  Jf Arnould; R Le Floch
Journal:  Ann Burns Fire Disasters       Date:  2015-03-31

Review 4.  Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?

Authors:  Alexandre Alanio; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Stéphane Bretagne
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

Review 5.  Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?

Authors:  Danièle Maubon; Cécile Garnaud; Thierry Calandra; Dominique Sanglard; Muriel Cornet
Journal:  Intensive Care Med       Date:  2014-08-05       Impact factor: 17.440

6.  Microsatellite marker analysis as a typing system for Candida glabrata.

Authors:  F Foulet; N Nicolas; O Eloy; F Botterel; J-C Gantier; J-M Costa; S Bretagne
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

7.  Effect of the major repeat sequence on mitotic recombination in Candida albicans.

Authors:  Paul R Lephart; Paul T Magee
Journal:  Genetics       Date:  2006-10-08       Impact factor: 4.562

8.  Use of microsatellite markers and gene dosage to quantify gene copy numbers in Candida albicans.

Authors:  J-M Costa; O Eloy; F Botterel; G Janbon; S Bretagne
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  Endemic genotypes of Candida albicans causing fungemia are frequent in the hospital.

Authors:  Pilar Escribano; Marta Rodríguez-Créixems; Carlos Sánchez-Carrillo; Patricia Muñoz; Emilio Bouza; Jesús Guinea
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

10.  Comparison of microsatellite length polymorphism and multilocus sequence typing for DNA-Based typing of Candida albicans.

Authors:  Dea Garcia-Hermoso; Odile Cabaret; Gael Lecellier; Marie Desnos-Ollivier; Damien Hoinard; Dorothée Raoux; Jean-Marc Costa; Françoise Dromer; Stéphane Bretagne
Journal:  J Clin Microbiol       Date:  2007-10-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.